Are Women with Sjögren's Syndrome Androgen-Deficient?

Journal of Rheumatology

Volumn 30, Issue 11, 2003, Pages 2413-2419

  Sullivan, David A ^a   Bélanger, Alain ^b   Cermak, Jennifer M ^b   Bérubé, René ^b   Papas, Athena S ^b   Sullivan, Rose M ^b   Yamagami, Hiroko ^b   Dana, M Reza ^b   Labrie, Fernand ^b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

Androgens; Dry eye; Estrogens; Sj gren's syndrome

Indexed keywords

ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTENEDIONE; ANDROSTERONE DERIVATIVE; ANDROSTERONE GLUCURONIDE; ESTRADIOL; ESTROGEN; ESTRONE; PRASTERONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRY EYE; ESTROGEN BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HYPOTHESIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PATHOGENESIS; PRIORITY JOURNAL; SJOEGREN SYNDROME;

ANDROGENS; CASE-CONTROL STUDIES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MIDDLE AGED; OSMOLAR CONCENTRATION; SJOGREN'S SYNDROME;

EID: 0041938078     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Labrie F, Bélanger A, Simard J, Luu-The V. Labrie C. DHEA and peripheral androgen and estrogen formation: Intracrinology. Ann NY Acad Sci 1995;774:16-28.
2. Schaumberg DA, Sullivan DA, Dana MR. Epidemiology of dry eye syndrome. Adv Exp Med Biol 2002;506:989-98.
3. Lemp MA. Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J 1995;21:221-32.
4. Homma M, Sugai S, Tojo T, Miyasaka N, Akizuki M, editors. Sjögren's syndrome. State of the art. Amsterdam: Kugler Press; 1994.
5. Sullivan DA, Wickham LA, Krenzer KL, Rocha EM, Toda I. Aqueous tear deficiency in Sjögren's syndrome: Possible causes and potential treatment. In: Pleyer U, Hartmann C, Sterry W, editors. Oculodermal diseases - Immunology of bullous oculo-muco-cutaneous disorders. Buren, The Netherlands: Aeolus Press; 1997:95-152.
6. Driver PJ, Lemp MA. Meibomian gland dysfunction. Surv Ophthalmol 1996;40:343-67.
7. Krenzer KL, Cermak JM, Tolls DB, Papas AS, Dana MR, Sullivan DA. Comparative signs and symptoms of dry eye in primary and secondary Sjögren's syndrome and meibomian gland disease [abstract]. Invest Ophthalmol Vis Sci 1999;40:S2864.
8. Nabata H, Horiuchi H, Miyata K, Tsuru T, Machinami R. Histopathological study of the human meibomian glands [abstract]. Invest Ophthalmol Vis Sci 1994;35 Suppl:1789.
9. Hykin PG, Bron AJ. Age-related morphological changes in lid margin and meibomian gland anatomy. Cornea 1992;11:334-42.
10. Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol 1995;113:1266-70.
11. Sullivan DA, Wickham LA, Rocha EM, Kelleher RS, Silveira LA, Toda I. Influence of gender, sex steroid hormones and the hypothalamic-pituitary axis on the structure and function of the lacrimal gland. Adv Exp Med Biol 1998;438:11-42.
12. Xu G, Shang H, Zhu F. Measurement of serum testosterone level in female patients with dry eye [abstract]. Proceedings of the International Congress of Ophthalmology Meeting; Toronto, Canada; 1994.
13. Sullivan DA, Edwards J. Androgen stimulation of lacrimal gland function in mouse models of Sjögren's syndrome. J Ster Biochem Mol Biol 1997;60:237-45.
14. Bizzarro A, Valentini G, Di Marinto G, Daponte A, De Bellis A, Iacono G. Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome. J Clin Endocrinol Metab 1987;64:32-6.
15. Lagresa MNS, Suarez NM, Lescaille DV, Lagresa CMS. Inductores de lágrimas: Andrógenos y gammaglobulinas humanas. Rev Cubana Oftalmol 2000;13:35-43.
16. Bruckner R. Uber einem erfolgreich mit perandren behandelten fall von Sjogren'schem symptomen komplex. Ophthalmologica 1945;110:37-42.
17. Sullivan DA, Sullivan BD, Evans JE, et al. Androgen deficiency, meibomian gland dysfunction and evaporative dry eye. Ann NY Acad Sci 2002;966:211-22.
18. Mamalis N, Harrison DY, Hiura G, et al. Dry eyes and testosterone deficiency in women [abstract]. In: Abstracts of the Centennial Annual Meeting of the American Academy of Ophthalmology 1996, Chicago, Illinois: 132.
19. Labrie F, Belanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997;82:2396-402.
20. Belanger A, Candas B, Dupont A, et al. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J Clin Endocrinol Metab 1994;79:1086-90.
21. Labrie F. Intracrinology. Mol Cell Endocrinol 1991;78:C113-8.
22. Belanger A. Determination of non-conjugated and conjugated steroids in human plasma. In: Gorog S, editor. Advances in steroid analysis '93: Proceedings from the 5th Symposium on the Analysis of Steroids, Szombathely, Hungary, May 3-5, 1993. Budapest: Akademia Kiado; 1994:99-110.
23. Labrie F, Bélanger A, Cusan L, Candas B. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J Clin Endocrinol Metab 1997;82:2403-9.
24. Labrie F, Diamond P, Cusan L, Gomez J-L, Bélanger A, Candas B. Effect of 12-month DHEA replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 1997;82:3498-505.
25. Labrie F, Bélanger A, Luu-The V, et al. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: Its role during aging. Steroids 1998;63:322-8.
26. Labrie F, Luu-The V, Lin SX, et al. The key role of 17β -hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997;62:148-58.
27. Lahita RG, Bradlow HL, Kunkel HG, Fishman J. Increased 16a-hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 1981;53:174-8.
28. Carlsten H, Tarkowski A, Holmdahl R, Nilsson LA. Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol 1990;80:467-73.
29. Ahmed SA, Aufdemorte TB, Chen JR, Montoya AI, Olive D, Talal N. Estrogen induces the development of autoantibodies and promotes salivary gland lymphoid infiltrates in normal mice. J Autoimmunity 1989;2:543-52.
30. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Assessment of the European Classification Criteria for Sjogren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren's Syndrome. Ann Rheum Dis 1996;55:116-21.
31. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
32. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
33. Berube R, Gauvin D, Blais M, Beaudoin J, Noreau L, Bélanger A. Determination of testosterone, 5-androstene-3β, 17β-diol, dehydroepiandrosterone and 4-androstenedione in human serum using high resolution gas chromatography and electron impact mass spectrometry [abstract]. Proceedings of the 47th ASMS Conference on Mass Spectrometry and Allied Topics; June 1999, Dallas, Texas.
34. Berube R, Malenfant J, Gauvin D, et al. Quantitation of androgenic and estrogenic steroids in rat and monkey serum using gas chromatography and negative chemical ionization mass spectrometry [abstract]. Proceedings of the 48th ASMS Conference on Mass Spectrometry and Allied Topics; June 2000, Long Beach, California.
35. Belanger P, Paradis D, Gagné D, Bérubé R, Bélanger A. Determination of androsterone glucuronide and androstane-3a, 17β-diol glucuronide in human plasma by turbo ionspray LC-MS MS [abstract]. Proceedings of the 48th ASMS Conference on Mass Spectrometry and Allied Topics; June 2000, Long Beach, California.
36. Council of Affiliated Menopause Societies, International Menopause Society. Menopause core curriculum study guide. [cited June 10, 2003] Website: www.menopause.org/edumaterials/studyguide/studyguide.html
37. Valtysdottir ST, Wide L, Hällgren B. Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function. J Rheumatol 2001;28:1259-65.
38. Jungers P, Khalil N, Pelissier C, Cougados M, Tron F, Bach J-F. Low plasma androgens in women with active or quiescent systemic lupus erythematosus. Arthritis Rheum 1982;25:454-7.
39. Lahita RG, Bradlow HL, Ginzler E, Pang S, New M. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987;30:241-8.
40. Derksen RH. Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus. Semin Arthritis Rheum 1998;27:335-47.
41. Masi AT, Josipovic DB, Jefferson WE. Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): Gas-liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion. Semin Arthritis Rheum 1984;14:1-23.
42. Cutolo M, Masi AT. Do androgens influence the pathophysiology of rheumatoid arthritis? Facts and hypotheses [editorial]. J Rheumatol 1998;25:1041-7.
43. Cutolo M, Foppiani L, Prete C, et al. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 1999;26:282-8.
44. Masi AT, Bijlsma JW, Chikanza IC, Pitzalis C, Cutolo M. Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives. Semin Arthritis Rheum 1999;29:65-81.
45. Feher KG, Feher T. Plasma dehydroepiandrosterone, dehydroepiandrosterone sulphate and androsterone sulphate levels and their interaction with plasma proteins in rheumatoid arthritis. Exp Clin Endocrinol 1984;84:197-202.
46. Sambrook PN, Eisman JA, Champion GD, Pocock NA. Sex hormone status in postmenopausal women with rheumatoid arthritis. Arthritis Rheum 1988;31:973-8.
47. Cutolo M, Balleari E, Giusti M, Monachesi M, Accardo S. Sex hormone status in women suffering from rheumatoid arthritis. J Rheumatol 1986;13:1012-23.
48. Hum DW, Belanger A, Levesque E, et al. Characterization of UDP-glucuronosyltransferases active on steroid hormones. J Steroid Biochem Mol Biol 1999;69:413-23.
49. Beeson PB. Age and sex associations of 40 autoimmune diseases. Am J Med 1994;96:457-62.
50. Ahmed SA, Penhale WJ, Tatal N. Sex hormones, immune responses and autoimmune diseases. Am J Pathol 1985;121:531-51.
51. Homo-Delarche F, Fitzpatrick F, Christeff N, Nunez EA, Bach JF, Dardenne M. Sex steroids, glucocorticoids, stress and autoimmunity. J Ster Biochem Mol Biol 1991;40:619-37.
52. Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocr Rev 1996;17:369-84.
53. Cutolo M, Sulli A, Seriolo B, Masi AT. Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995;13:217-26.
54. Kanda N, Tsuchida T, Tamaki K. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1999;42:328-37.
55. Kanda N, Tsuchida T, Tamaki K. Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:1703-11.
56. Jansson L, Holmdahl R. Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm Res 1998;47:290-301.
57. Araneo BA, Dowell T, Diegel M, Daynes RA. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and g-interferon, but not IL-2 by activated murine T cells. Blood 1991;78:688-99.
58. Li ZG, Danis VA, Brooks PM. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol 1993; 11: 157-62.
59. Harbuz MS, Perveen-Gill Z, Lightman SL, Jessop DS. A protective role for testosterone in adjuvant-induced arthritis. Br J Rheumatol 1995;34:1117-22.
60. Appelmans M. La Kerato-conjonctivite seche de Gougerot-Sjogren. Arch Ophtalmologie 1948;81:577-88.
61. Shoenfeld Y, Krause I, Blank M. New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation. Ann Rheum Dis 1997;56:5-11.
62. Cutolo M, Balleari E, Giusti M, Intra E, Accardo S. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1-5.
63. 2002 Physicians' desk reference. 56th ed. Montvale, NJ: Medical Economics Co.; 2002.
64. Rebar RW. Practical evaluation of hormonal status. In: Yen SSC, Jaffe RB, Barbieri RL, editors. Reproductive endocrinology: physiology, pathophysiology, and clinical management. Philadelphia: WB Saunders Company; 1999:709-47.
65. Doerr P, Pirke KM. Cortisol-induced suppression of plasma testosterone in normal adult males. J Clin Endocrinol Metab 1976;43:622-9.
66. Navarro MA, Nolla JM, Machuca MI, et al. Salivary testosterone in postmenopausal women with rheumatoid arthritis. J Rheumatol 1998;25:1059-62.
67. Schuurs AHWM, Verheul HAM. Effects of gender and sex steroids on the immune response. J Steroid Biochem 1990;35:157-72.
68. Lahita RG. The connective tissue diseases and the overall influence of gender. Int J Fertil 1996;41:156-65.
69. Lahita RG, Bradlow HL, Kunkel HG, Fishman J. Alterations of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum 1979;22:1195-8.
70. Sato EH, Sullivan DA. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjögren's syndrome. Invest Ophthalmol Vis Sci 1994;35:2632-42.
71. Purohit A, Ghilchik MW, Duncan L, et al. Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 1995;80:3052-8.
72. Macdiarmid F, Wang D, Duncan LJ, Purohit A, Ghilchick MW, Reed MJ. Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor alpha. Mol Cell Endocrinol 1994;106:17-21.
73. Nestler JE. Interleukin-1 stimulates the aromatase activity of human placental cytotrophoblasts. Endocrinol 1993;132:566-70.
74. Rocha EM, Wickham LA, Huang Z, et al. Presence and testosterone influence on the levels of anti- and pro-inflammatory cytokines in lacrimal tissues of a mouse model of Sjögren's syndrome. Adv Exp Med Biol 1998;438:485-91.
75. Robinson CP, Cornelius J, Bounous DE, Yamamoto H, Humphreys-Beher MG, Peck AB. Characterization of the changing lymphocyte populations and cytokine expression in the exocrine tissues of autoimmune NOD mice. Autoimmunity 1998;27:29-44.
76. Jones DT, Monroy D, Ji Z, Pflugfelder SC. Alterations of ocular surface gene expression in Sjogren's syndrome. Adv Exp Med Biol 1998;438:533-6.
77. Schirra F, Suzuki T, Dickinson D, Townsend DJ, Gipson IK, Sullivan DA. Presence of steroidogenic enzyme mRNAs in human lacrimal and meibomian glands, as well as corneal and conjunctival epithelial cells [abstract]. Abstracts of the European Association for Vision and Eye Research Meeting 2002; Alicante, Spain.
78. Sokoloff MH, Tso CL, Kaboo R, et al. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines. Cancer 1996;77:1862-72.
79. Blais Y, Sugimoto K, Carriere MC, Haagensen DE, Labrie F, Simard J. Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1 alpha on a polipoprotein D and GCDFP-15 expression in human breast cancer cells. Int J Cancer 1995;62:732-7.